PharmaBoardroom

Cannabinoid Drugs, Medicinal Cannabis & Opioid Drugs: India

Cannabinoid drugs, medicinal cannabis & opioid drugs in India - a comprehensive legal overview. Prepared in association with Nishith Desai &…

Biosimilars & Biologics: India

An insight into biosimilars & biologics in Indian Pharma. Prepared in association with Nishith Desai & Associates, a leading law firm in…

Localization: India

The key facts about the localization in Indian Pharma. Prepared in association with Nishith Desai & Associates, a leading law firm in India, this…

Orphan Drugs & Rare Diseases: India

Want to know more about orphan drugs & rare diseases in India? Read on! Prepared in association with Nishith Desai & Associates, a leading law…

Gergely Jánoki – CEO, Medi-Radiopharma, Hungary

Gergely Jánoki CEO of Medi-Radiopharma shares his insights on the activities of the company, the trends in the radiopharmaceutical industry while…

A Collaborative Approach to Fighting Diabetes in Puerto Rico

In Puerto Rico, approximately 16 percent of the adult population has diabetes, one the highest prevalence in the world, compared to 10 percent in the…

Biocon’s New Facility & Expansion in APAC

Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with a new manufacturing facility and an…

Jan Škrha – President, Czech Diabetes Society (ČDS)

Jan Škrha, president of the Czech Diabetes Society (ČDS), provides insight into the most crucial advances in the quality care of Diabetes, which…

Three More Key Issues for Pharma: Regulatory Assertiveness,…

Eurasia Group’s Aditya Bhattacharji tackles three more key geopolitical issues that global pharma needs to be cognizant of: the world’s leading…

Qinghua Wang – CEO & Founder, Innogen, China

The rate of diabetes in China has exploded: the number of diabetic patients has surpassed 100 million and is expected to increase to 150 million by…

Tao Chen – CEO, Agsea & Head of Business Development,…

Tao Chen, head of business development of Absea and CEO of the new spin-out Agsea, is entering the world of immunodiagnostics with a comprehensive…

Key Regulatory Developments in Indian Medtech 2019

Regulation of medical devices in India has speedily evolved in the preceding two years. Before the introduction of the Medical Device Rules, 2017…

Tagged with DIA